Zobrazeno 1 - 10
of 268
pro vyhledávání: '"Wojciech Jurczak"'
Autor:
Junji Suzumiya, Seok-Goo Cho, Keum Young Ahn, Marek Trneny, Eduardo Yanez Ruiz, Christian Buske, Leslie Popplewell, Jose Mario Mariz, Michinori Ogura, Larry W. Kwak, Olga Samoilova, Tobias F. Menne, Hideyuki Nakazawa, Jin Seok Kim, Edvard Zhavrid, Gayane Tumyan, Nikolai Ilyin, Sunghyun Kim, Sang-Joon Lee, Wojciech Jurczak, Won Seog Kim, Juan-Manuel Sancho, A. Martínez
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
INTRODUCTION: This double-blind, parallel-group, active-controlled phase III trial (NCT02260804) assessed CT-P10 and rituximab safety and efficacy in patients with previously untreated low-tumor-burden follicular lymphoma (LTBFL), including after a s
Autor:
Frederic Peyrade, Graham P. Collins, Yihua Lee, Jutta K. Neuenburg, Michael Wang, Robert T. Chen, Geoffrey Chong, Karl Eckert, Constantine S. Tam, Radhakrishnan Ramchandren, Lionel Karlin, Ka Lung Wu, Mark Bishton, Paul Eliadis, Wojciech Jurczak
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-8 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Ibrutinib plus venetoclax, given with an ibrutinib lead-in, has shown encouraging clinical activity in early phase studies in mantle cell lymphoma (MCL). The ongoing phase 3 SYMPATICO study evaluates the safety and efficacy of concurrently administer
Autor:
KeumYoung Ahn, Mariana Vasilica, Christian Buske, Rajnish Nagarkar, Edvard Zhavrid, Aliaksandr Prokharau, Sung-Hyun Kim, Juan-Manuel Sancho, Michinori Ogura, Won Seog Kim, Wojciech Jurczak, Jose Angel Hernandez-Rivas, Jin Seok Kim, Sang Joon Lee, Larry W. Kwak
Publikováno v:
Blood Adv
Rituximab biosimilars are a cornerstone of treatment of advanced-stage follicular lymphoma (FL). This double-blind, parallel-group, phase 3 trial randomized (1:1) adults (≥18 years) with stage III to IV indolent B-cell lymphoma, including grades 1
Publikováno v:
Acta Haematologica Polonica. 52:202-206
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has affected the health of the entire population. Neoplastic diseases of the immune system are associated with increased COVID-related mortality. Vaccination is the only effective way to
Autor:
Iwona Hus, Wojciech Jurczak, Sebastian Giebel, Anna Czyż, Jan Maciej Zaucha, Ewa Lech-Marańda, Wiesław Wiktor Jędrzejczak, Tadeusz Robak, Lidia Gil, Tomasz Wróbel, Jan Walewski
Publikováno v:
Hematologia. 11:193-211
In Poland, 800–900 new cases of classical Hodgkin’s lymphoma (cHL) are diagnosed annually. Despite relatively good results of first-line treatment, 20–25% of patients relapse and the chances of their cure become much smaller. The paper presents
Autor:
Wiesław Wiktor Jędrzejczak, Jan Maciej Zaucha, Iwona Hus, Michal Szymczyk, Tadeusz Robak, Anna Czyż, Grzegorz Helbig, Krzysztof Lewandowski, Dariusz Wołowiec, Monika Prochorec-Sobieszek, Krzysztof Mądry, Lidia Gil, Jan Walewski, Ewa Lech-Marańda, Maria Bieniaszewska, Dominik Dytfeld, Małgorzata Sokołowska-Wojdyło, Sebastian Giebel, Krzysztof Giannopoulos, Grzegorz W. Basak, Krzysztof Jamroziak, Tomasz Sacha, Jan Styczyński, Tomasz Czerw, Agnieszka Wierzbowska, Tomasz Wróbel, Wojciech Jurczak, Jerzy Holowiecki, Joanna Drozd-Sokołowska, Artur Jurczyszyn
Publikováno v:
National Information Processing Institute
The number of newly diagnosed haematological malignancies in Polish adults and children is about 9,000 a year, which constitutes about 5.5% of all malignancies in the country. Adult patients with haematological malignancies are diagnosed and treated
Publikováno v:
Expert opinion on biological therapy
Introduction: Patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) require further treatment options, especially in cases that cannot tolerate stem cell transplant or cytotoxic chemotherapy. CD19 has emerged as an attractive
Publikováno v:
Hematology. 26:860-869
Immune thrombocytopenia (ITP) is a rare disease, characterized by increased platelet destruction/suboptimal platelet production, leading to thrombocytopenia and risk of severe bleeding events. Interviews with 23 physicians and 12 payors, a survey wit
Autor:
Gandhi Damaj, Deyaa Adib, Sarit Assouline, Michael Dickinson, John Radford, Gilles Salles, Anna Schmitt, Wojciech Jurczak, Jay Yang, Tycel Phillips, Franck Morschhauser, Maciej Kazmierczak, Aristeidis Chaidos, Phillip L. Campbell, Connie Lee Batlevi, Pamela McKay, Hervé Tilly, Stephen Opat, Vincent Ribrag, Jennifer Whalen, Shefali Agarwal
Publikováno v:
Lancet Oncol
Summary Background Activating mutations of EZH2, an epigenetic regulator, are present in approximately 20% of patients with follicular lymphoma. We investigated the activity and safety of tazemetostat, a first-in-class, oral EZH2 inhibitor, in patien
Publikováno v:
Transactions of FAMENA
Volume 44
Issue 3
Volume 44
Issue 3
Aluminium alloy sheets have come into widespread use in the design of stringer-stiffened aerospace structures. This paper evaluates experimentally and numerically the response of stringer-stiffened Alclad 7075-T6 aluminium alloy panels subjected to i